Elaine Johnstone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Elaine Johnstone has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Beny Alex
Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, Oncology Division, Rambam Medical Center, Haifa, Israel, affiliated to The Technion, Haifa, Israel
1 shared publicationC.D. Frith
1 shared publication- Einat Shacham-Shmueli
Division of Medical Oncology, Sheba Medical Center, Ramat-Gan, Israel
1 shared publication Eli Brazowsky
Department of Pathology
1 shared publication- Geva
Gastrointestinal Malignancies Service, Oncology Division 1
1 shared publication J Done
1 shared publication
Latest Publications
- 27 February 2015
- Published by Taylor & Francis in Cancer Investigation
- Vol. 33 (4) , 89-97
The Predictive Role of ERCC1 Status in Oxaliplatin Based Neoadjuvant Therapy for Metastatic Colorectal Cancer (mCRC) to the Liver
Increased expression of excision repair cross-complementing 1 (ERCC1) in mCRC patients could be related to their response to Oxaliplatin based chemotherapy. We evaluated ERCC1 mRNA expression levels in primary bowel and liver metastases of 51 patients, and correlated with pathologic parameters and clinical outcomes. A significant negative correlation was detected between primary tumor ERCC1 and both the extent of clear surgical margins (P = 0.0011) and the percent of liver metastasis necrosis (P = 0.0167). No relationship was observed between ERCC1 expression and survival. Further study is needed to assess the promising role of ERCC1 expression as a predictive marker benefiting subgroups for Oxaliplatin.
- 27 February 2015
- Published by Taylor & Francis in Cancer Investigation
- Vol. 33 (4) , 89-97
The Predictive Role of ERCC1 Status in Oxaliplatin Based Neoadjuvant Therapy for Metastatic Colorectal Cancer (mCRC) to the Liver
Increased expression of excision repair cross-complementing 1 (ERCC1) in mCRC patients could be related to their response to Oxaliplatin based chemotherapy. We evaluated ERCC1 mRNA expression levels in primary bowel and liver metastases of 51 patients, and correlated with pathologic parameters and clinical outcomes. A significant negative correlation was detected between primary tumor ERCC1 and both the extent of clear surgical margins (P = 0.0011) and the percent of liver metastasis necrosis (P = 0.0167). No relationship was observed between ERCC1 expression and survival. Further study is needed to assess the promising role of ERCC1 expression as a predictive marker benefiting subgroups for Oxaliplatin.
- 1 January 1990
- Published by Elsevier in Schizophrenia Research
- Vol. 3 (1) , 91
Pregnancy and birth complications as causes of psychiatric illness in adult life: A study utilizing the perinatal mortality survey (1958)
- 1 January 1990
- Published by Elsevier in Schizophrenia Research
- Vol. 3 (1) , 91
Pregnancy and birth complications as causes of psychiatric illness in adult life: A study utilizing the perinatal mortality survey (1958)